10 results
BioNTech, Pfizer could deliver Omicron-adapted COVID-19 vaccines in October
BioNTech and Pfizer announced trials this month for their adapted COVID-19 vaccines, to fight faster-spreading Omicron ...
Vaccine Targeting Fast-Spreading Omicron Subvariants Could Be Ready For Fall As Pfizer, BioNTech Announce Trials
BioNTech and its U.S. partner Pfizer have already begun manufacturing Covid-19 boosters that are adapted for multiple Omicron ...
COVID-19 vaccine maker BioNTech expects updated omicron-specific shots by October
BioNTech, with its partner Pfizer, expects to begin deliveries of two omicron-adapted vaccines as soon as October in time for ...
BioNTech reports strong first half, expects demand to grow
BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, has reported higher revenue and net profit in the ...
BioNTech Says Omicron-Specific COVID Vaccines Could be Delivered as Soon as This Fall
The company that manufactures the Pfizer COVID vaccine says that it could potentially begin deliveries on an ...
NBC Chicago on MSN.com4h
Pfizer, BioNTech to study 'bivalent' booster as FDA weighs approach
The small-scale study is part of the companies’ efforts to update their vaccine in time for a potential fall vaccination ...
BioPharma Dive12d
UPDATE 2-BioNTech expects Omicron-adapted vaccine deliveries as soon as October
BioNTech expects to begin deliveries of two Omicron-adapted vaccines as soon as October, which will help spur demand in the fourth quarter, the German biotech firm said on Monday as it reaffirmed its ...
Business Highlights: Axios sold, Pfizer buying spree
Axios Media is being acquired by Cox Enterprises, which says it plans to push the online news provider into new markets while broadening its coverage. Axios, citing sources, reported Monday that the ...
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design
Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) today announced that the companies have initiated a randomized, active-controlled, observer-blind Phase 2 study to ...
BioNTech, Pfizer sue CureVac in U.S. over COVID-19 vaccine patent claims
COVID-19 vaccine maker BioNTech said on Tuesday that it and partner Pfizer have filed a complaint with the U.S. District ...